Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Many congratulations to Jeremy Rodrigues who has been awarded an NIHR Postdoctoral Fellowship for a project entitled “Improving treatment decision making in hand surgery”. This aims to understand the variation in Dupuytren’s disease intervention in the NHS and to improve decision making in treatments.

Dupuytren’s disease affects up to 1 in 10 people in Britain, and is currently treated in a variety of ways including injections and surgery. Patient-Reported Outcome Measures (PROMs) are already captured nationally but there is scope to improve them, and to better use the data generated.

Jeremy’s work will examine existing PROMs, understand why patients and surgeons choose treatments, and study the effect of treatment.  The findings will be combined in a decision support package to guide treatment choice.

Commenting on his award,  Jeremy stated “I am grateful to NIHR and the British Society for Surgery of the Hand for supporting this project and my further training.  This award reflects the wide-ranging academic and clinical support that I receive in Oxford and Thames Valley.  I am excited about starting the fellowship, which I believe will contribute to improved care for people with a common hand condition.”

FUNDING BODY

NIHR NHS_Logo_Funded by Stamp.jpg

Similar stories

Professor Michael Dustin appointed new Chair in Molecular Immunology

A generous gift from the Kennedy Trust for Rheumatology Research has enabled the creation of a new Chair in Molecular Immunology at the University of Oxford.

Empowering data science for single-cell analysis in Zimbabwe

An innovative computational biology training module was launched in November 2022 at the African Institute of Biomedical Science and Technology (AiBST) in Harare, Zimbabwe, where MSc students were trained in single-cell RNA sequencing data analysis.

T-cell coreceptors are well endowed—with kinases!

The kinase occupancy of CD4 and CD8 coreceptors is high, according to a new study published in PNAS.

Two prestigious Hunterian Professorships awarded to NDORMS researchers

Conrad Harrison and Tom Layton have both been awarded Hunterian Professorships for 2022 by the Royal College of Surgeons of England

Adalimumab is found to be a cost-effective treatment for early-stage Dupuytren’s disease

Researchers at the Kennedy Institute of Rheumatology and Oxford Population Health’s Health Economics Research Centre have found that anti-TNF treatment (adalimumab) is likely to be a cost-effective treatment for people affected by early-stage Dupuytren’s disease.

Patients like me

What can patients learn from the experiences of people like them who’ve already had a hip replacement? A new tool called ‘Patients like me’ helps answer some of the questions about pain, complications and how long the prosthesis might last.